Close
VOLUNTARY ANNOUNCEMENT - RISVUTATUG REZETECAN FOR INJECTION (HS-20093) FOR OSTEOSARCOMA INCLUDED IN PRIORITY REVIEW AND APPROVAL PROCEDURE OF THE NMPA
Attachments
HKEX-EPS_20260922_12341168_0.PDF
Supplied by ©
Terms of Service
Cookie Policy